CFIUS regulations can affect far more than defense contractors or telecommunications providers. For industrial companies, foreign investment may raise review questions when a business develops critical technologies, supports specified infrastructure, holds sensitive personal data or operates near certain military facilities. Understanding these areas early can help companies identify filing obligations and assess transaction risk before a deal reaches closing.
The framework described here reflects a July 2020 overview of the Committee on Foreign Investment in the United States (CFIUS). Regulatory requirements can change, so companies should verify the rules applicable to a specific transaction and date.
Why CFIUS matters to industrial companies
CFIUS is an interagency committee chaired by the U.S. Department of the Treasury. It assesses the national security implications of certain foreign investments in U.S. businesses. Its membership includes departments responsible for defense, homeland security, justice, commerce, energy and other areas, with additional agencies able to participate in specific matters.
Historically, CFIUS was most closely associated with sectors such as defense, telecom, aerospace and weapons manufacturing. Its reach has expanded to include a broader range of commercial activity. The 2020 overview highlighted advanced technologies, large datasets containing U.S. person information, strategic resources and biotechnology as areas that may draw attention.
That wider scope is relevant to industrial automation. A company producing or developing controlled technology, working on covered critical infrastructure, or collecting substantial sensitive data may warrant closer screening when foreign investment is proposed. The commercial purpose of a technology does not, by itself, rule out national security concerns.
CFIUS regulations: transaction types and coverage
FIRRMA, enacted in August 2018, expanded CFIUS authority. The reforms covered certain non-controlling investments as well as control transactions, added review of some real estate transactions, and introduced mandatory filing requirements for specified deals. In the framework presented in 2020, CFIUS could review voluntary notifications, mandatory notifications and certain real estate notifications.
Control transactions and covered investments
CFIUS can review transactions in which a foreign person obtains control of a U.S. business. It can also review some investments that do not confer control when the target is a “TID U.S. business”—a business involving technology, infrastructure or data—and the foreign investor receives particular rights or access.
Potentially relevant rights include access to material nonpublic technical information, personal data or critical infrastructure information; board membership or observer rights; or other involvement in the business’s operations beyond ordinary voting rights. A TID U.S. business may be one that:
- Produces, designs, tests, manufactures, fabricates or develops critical technologies.
- Performs specified functions involving covered critical infrastructure.
- Maintains or collects large amounts of sensitive personal data about U.S. citizens, or sensitive data associated with military personnel.
The 2020 materials noted that a passive investment below 10% generally would not amount to control. They also described exceptions for certain investors based in the United Kingdom, Canada and Australia in relation to covered-investment jurisdiction. These details should be checked against the rules governing the transaction in question.
Mandatory filings and critical technology
The 2020 framework included mandatory filings for certain critical technology investments and transactions involving a foreign government’s substantial interest in a TID U.S. business. At that time, the critical technology filing test was linked to specified industries, including semiconductor manufacturing, aircraft and engine production, biotechnology research, computer manufacturing and selected energy-related activities.
A proposed revision announced in May 2020 would replace the industry-code part of the mandatory filing test with an export-control-focused test. Under the proposal, a filing could be required where the U.S. business developed critical technology, an export license would be required to transfer that technology to a foreign party connected with the transaction, and the relevant foreign person met specified ownership or investment criteria. Because this was described as a proposed change, it should not be treated as a statement of current filing requirements.
Critical technologies in the presentation included items controlled under the International Traffic in Arms Regulations or the Commerce Control List, certain nuclear equipment and materials, select agents and toxins, and emerging or foundational technologies. The materials also pointed to developing export controls as a factor that could affect how companies assess technology and deal obligations.
Real estate and investment fund considerations
CFIUS authority also extended to certain foreign purchases, leases or concessions involving U.S. real estate. The 2020 overview identified property at airports or maritime ports, near specified military installations, within an extended range of especially sensitive installations, or within 12 nautical miles of certain coastal military installations. It also described exceptions for some individual-unit transactions, dense urban areas and qualifying investors from excepted foreign states.
Investment fund structures can raise separate questions. According to the framework presented, a fund controlled by a U.S. general partner with its principal place of business in the United States was generally treated as a U.S. investor, even if foreign limited partners participated, provided they were true limited partners. A foreign limited partner’s advisory board participation would not alone trigger jurisdiction if, among other conditions, the foreign investor could not control fund decisions and did not gain access to specified sensitive information through that role.
Build CFIUS screening into transaction diligence
For industrial companies and investors, the practical starting point is to assess CFIUS exposure early rather than waiting until closing preparations. The 2020 materials recommended examining whether a mandatory filing might apply and whether a transaction could attract CFIUS interest. Relevant diligence areas include:
- Export-control status of the company’s products, software, technology and technical information.
- Government contracts and the nature of any covered infrastructure work.
- The significance of the company’s technology in the United States and abroad.
- Data held or collected by the business, including whether it may be sensitive personal data.
- Transaction terms, investor rights and appropriate closing conditions.
Foreign investment screening was also expanding in the European Union and its member states. The 2020 overview described an EU cooperation framework and national measures that were extending screening to sectors such as healthcare and biotechnology. For cross-border transactions, this meant that deal planning could involve multiple review regimes, not only CFIUS.
Conclusion
CFIUS regulations create transaction considerations for industrial businesses whose technologies, infrastructure activities, data or real estate may intersect with national security concerns. A disciplined review of the target business, investor rights, export controls and filing requirements can help decision-makers identify issues early and plan transaction terms accordingly. Because the rules summarized here reflect a 2020 presentation, confirm the requirements in force before relying on them for a current deal.